AIG:NYSEAmerican International Group, Inc. New Analysis
Data as of 2026-03-10 - not real-time
$77.62
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
American International Group (AIG) is trading at $77.62, just above its 20‑day SMA of 79.01 and comfortably above the 50‑day SMA of 77.83, while the 200‑day SMA sits near 79.90, indicating a neutral price stance. The 14‑day RSI of 46.3 suggests the stock is neither overbought nor oversold, and the MACD histogram is negative with a bearish signal, pointing to short‑term downside pressure. AIG holds strong support at $74.56 and faces resistance near $81.62, with a 30‑day volatility of 23.9% and a low beta of 0.55, implying modest market sensitivity.
Fundamentally, the company posted a 51% YoY jump in Q4 adjusted EPS to $1.96, beating estimates, and generated $11.26 B of free cash flow, supporting its 2.32% dividend yield and a modest 32% payout ratio. Despite a 7.2% revenue decline, margins remain healthy (gross 34.1%, operating 13.8%) and the forward PE of 8.76 is well below the industry average of 17.38, signaling relative undervaluation. The DCF‑derived fair value of $292.7 suggests a potential upside of roughly 12.7% from current levels, and the “Extreme Greed” sentiment in the fear‑greed index adds momentum to the bullish case.
Fundamentally, the company posted a 51% YoY jump in Q4 adjusted EPS to $1.96, beating estimates, and generated $11.26 B of free cash flow, supporting its 2.32% dividend yield and a modest 32% payout ratio. Despite a 7.2% revenue decline, margins remain healthy (gross 34.1%, operating 13.8%) and the forward PE of 8.76 is well below the industry average of 17.38, signaling relative undervaluation. The DCF‑derived fair value of $292.7 suggests a potential upside of roughly 12.7% from current levels, and the “Extreme Greed” sentiment in the fear‑greed index adds momentum to the bullish case.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price near short‑term support levels
- Bearish MACD signal
- Neutral RSI and stable volume
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Strong EPS beat and free cash flow generation
- Undervalued valuation multiples versus peers
- Attractive dividend yield with sustainable payout
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- DCF fair‑value indicating significant upside
- Strategic acquisitions expanding growth platform
- Resilient business model across diversified insurance segments
Key Metrics & Analysis
Financial Health
Revenue Growth-7.20%
Profit Margin11.63%
P/E Ratio14.3
ROE7.40%
ROA1.73%
Debt/Equity24.41
P/B Ratio1.0
Op. Cash Flow$3.3B
Free Cash Flow$11.3B
Industry P/E17.4
Technical Analysis
TrendNeutral
RSI46.3
Support$74.56
Resistance$81.62
MA 20$79.01
MA 50$77.83
MA 200$79.90
MACDBearish
VolumeStable
Fear & Greed Index80.45
Valuation
Fair Value$292.71
Target Price$87.45
Upside/Downside12.66%
GradeUndervalued
TypeValue
Dividend Yield2.32%
Risk Assessment
Beta0.56
Volatility23.91%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.